2023
DOI: 10.1016/j.eclinm.2023.102304
|View full text |Cite
|
Sign up to set email alerts
|

First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCT

Shigeru Saito,
Johan Bennett,
Holger M. Nef
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
references
References 27 publications
0
0
0
Order By: Relevance